Geneva: The World Health Organisation (WHO) on Friday said it has suspended Gilead’s Remdesivir from its so-called prequalification list (an official list of medicines used as a benchmark for procurement by developing countries), after issuing guidance against its use in hospitalized COVID-19 patients, said media reports.
“Yes we have suspended it from the PQ (prequalification list),” Tarik Jasarevic said in an emailed response to Reuters, the reports added.
“The suspension is a signla to countries that WHO, in compliance with the treatment guidelines, does not recommend countries procure the drug for COVID.”
He added that the WHO was not aware that any international procurers were providing the drug to low-and middle-income countries, reports said.
Also Read: Govt Helpline Gives Emotional Support To Children Battling COVID
Balasore: A young man was allegedly beaten to death on the suspicion of having committed…
Mumbai: Bollywood celebrities have often had funny, at times bizarre experiences, mostly involving hero-worshipping, demanding fans.…
Bhubaneswar: Police have arrested the owner of a Jatra (theatre) group for allegedly duping an…
Sanskriti Talwar Faridkot (Punjab): For the third consecutive year, Balwinder Singh of Mallan village in…
Bhubaneswar: Rain may play spoilsport in Christmas and New Year celebrations in Odisha as the…
New Delhi: Netflix showed the way, Amazon Prime Video is following in their footsteps. Come…
This website uses cookies.